Quantexa, the global leader in Decision Intelligence (DI) solutions, announced on Friday the appointment of three high-profile industry experts to its Advisory Board. The new members are Ralph Schlosstein, former CEO of Evercore and former President of BlackRock (NYSE:BLK); Matthew Gould, former CEO of NHSX; and Sir Jeremy Fleming, former Director of GCHQ. These seasoned leaders bring expertise from finance, healthcare, and national security sectors, respectively.
The recent appointments come at a critical time for Quantexa. Following a successful $129 million Series E funding round led by GIC, the company has joined an elite group of UK tech companies achieving unicorn status. In addition, Quantexa has announced plans to invest over $155 million in the global AI industry over the next three years to assist clients in enhancing their use of AI for business growth and protection. By 2027, the company's total global investment in AI is expected to exceed $250 million.
Ralph Schlosstein brings a wealth of experience from investment banking sector to Quantexa's Advisory Board. His illustrious career includes a strategic role in taking the world's largest asset management firm public. His financial acumen will be crucial in shaping corporate strategy initiatives at Quantexa.
Matthew Gould, with his extensive background in healthcare and technology partnerships, joins the Advisory Board after his tenure as the British ambassador to Israel from 2010 to 2015. During this period, Gould launched the UK-Israel Technologies Hub in Tel Aviv to foster technology partnerships between UK and Israeli companies. He later played a significant role advising NHS on initiatives throughout the Covid-19 pandemic. His expertise will help Quantexa identify strategic focus areas and make decisions on commercial strategy.
Sir Jeremy Fleming joins the Advisory Board with over 30 years of experience in intelligence and technology. He was instrumental in developing the National Cyber Security Centre, striving to make the UK the safest place to conduct business online. His passion for transparency in government technology use will enhance Quantexa's capabilities in addressing emerging threats and opportunities.
"We are pleased to welcome Ralph Schlosstein, Matthew Gould, and Sir Jeremy Fleming to our Advisory Board," said Vishal Marria, CEO of Quantexa. "Their collective expertise in finance, healthcare, and national security will be invaluable as we continue to develop cutting-edge decision intelligence solutions that address the evolving needs of the market."
The new appointees expressed their excitement about joining Quantexa's Advisory Board and contributing to the company's growth strategy. Their collective expertise will undoubtedly aid Quantexa in its mission to empower organizations with innovative Decision Intelligence solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.